Look back at pharma news in week to December 14

tpl-week-in-review-700x466

By Barbara Obstoj-Cardwell. Editor

In terms of boardroom changes news last week, Gilead Sciences’ poaching of Roche Pharma head as its new chief executive attracted a great deal of attention. On the clinical trial front, there were disappointments for AstraZeneca, which reported another failure with its immuno-oncology drug Imfinzi, and for Axovant Sciences, which is dropping further development of its neurological candidate nelotanserin due to a Phase II failure. Meantime, on deal-making, despite its own failures in the Alzheimer’s space, Eli Lilly has entered into a licensing agreement to take over AC Immune’s investigational drug ACI-3024.

Gilead looks to a brand new day in cancer

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical